| FXAIX | USBOX | FXAIX / USBOX | |
| Total Expense Ratio | 0.01 | 1.11 | 1% |
| Annual Report Gross Expense Ratio | 0.01 | 1.52 | 1% |
| Fund Existence | 15 years | 41 years | - |
| Gain YTD | 1.998 | 0.996 | 201% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 753B | 315M | 239,048% |
| Annual Yield % from dividends | 1.10 | 0.42 | 263% |
| Returns for 1 year | 17.83 | -13.33 | -134% |
| Returns for 3 years | 75.94 | 12.34 | 616% |
| Returns for 5 years | 93.74 | 2.51 | 3,741% |
| Returns for 10 years | 310.97 | 43.03 | 723% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MMIJX | 25.65 | 0.15 | +0.59% |
| Victory Integrity Mid-Cap Value Member | |||
| FBTDX | 150.09 | 0.64 | +0.43% |
| Franklin Biotechnology Discovery C | |||
| FNCMX | 299.43 | N/A | N/A |
| Fidelity Nasdaq Composite Index | |||
| PAEAX | 22.06 | -0.09 | -0.41% |
| Putnam Dynamic Asset Allocation Gr A | |||
| TSPFX | 5.30 | -0.05 | -0.93% |
| Transamerica Small Cap Growth R4 | |||